Encube Ethicals has halted plans for a majority stake sale due to a valuation gap, with potential buyers offering up to $1.6 billion against the company's $2 billion target. Instead, the pharmaceutical firm is now eyeing an Initial Public Offering by 2027. …
Mumbai: Encube Ethicals has paused plans to sell a majority stake due to a valuation mismatch, said people familiar with the matter. Instead, the company is exploring the possibility of an initial pu… [+1530 chars]
